Company profile for Generate Biomedicines

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering Generative Biology™ to create breakthrough medicines. A fundamental shift in therapeutic development, driven by machine intelligence. Our machine learning algorithms analyze hundreds of millions of known proteins, looking for statistical patterns linking amino acid...
Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering Generative Biology™ to create breakthrough medicines. A fundamental shift in therapeutic development, driven by machine intelligence. Our machine learning algorithms analyze hundreds of millions of known proteins, looking for statistical patterns linking amino acid sequence, structure, and function.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
26 Landsdowne Street Cambridge, MA 02139
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/generatebiomedicines-to-initiate-global-phase-3-studies-of-gb-0895-a-long-acting-anti-tslp-antibody-for-severe-asthma-engineered-with-ai-302628234.html

PR NEWSWIRE
02 Dec 2025

https://www.fiercebiotech.com/biotech/flagship-launches-another-ai-powered-drug-discovery-company-expedition-medicines

FIERCE BIOTECH
22 Oct 2025

https://www.prnewswire.com/news-releases/generatebiomedicines-to-present-phase-1-results-for-ai-engineered-gb-0895-in-asthma-at-the-european-respiratory-society-international-congress-302566586.html

PR NEWSWIRE
25 Sep 2025

https://www.prnewswire.com/news-releases/generatebiomedicines-provides-update-on-its-platform-and-pipeline-powered-by-ai-at-the-43rd-annual-jp-morgan-healthcare-conference-302346582.html

PR NEWSWIRE
09 Jan 2025

https://www.businesswire.com/news/home/20231115950537/en

BUSINESSWIRE
15 Nov 2023

https://www.businesswire.com/news/home/20230612005121/en

BUSINESSWIRE
12 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty